EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?

Critical Reviews in Oncology/hematology
Mohamed AlorabiApar Kishor Ganti

Abstract

Treatment options for locally advanced squamous cell carcinoma of the head and neck (SCCHN) include either surgical resection followed by radiation or chemoradiation, or definitive chemoradiation for which single-agent cisplatin is the best studied and established. The increasing understanding of the molecular biology of SCCHN has led to an interest in the development of targeted therapies. The epidermal growth factor receptor (EGFR) is over-expressed in nearly 80-90% of cases of SCCHN and correlates with poor prognosis and resistance to radiation. Preclinical evidence showed that blocking EGFR restores radiation sensitivity and enhances cytotoxicity. This finding led to clinical trials evaluating this class of agents and the approval of cetuximab in combination with radiation for the treatment of locally advanced SCCHN. This review is focused on the anti-EGFR monoclonal antibodies and their role either with radiotherapy or chemoradiation in unresectable LA SCCHN.

References

Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·L X YangH J Wang
Mar 1, 1997·Immunotechnology : an International Journal of Immunological Engineering·C MateoR Pérez
Nov 20, 1997·Biochimica Et Biophysica Acta·T GoldkornK Matsukuma
Apr 13, 2000·International Journal of Radiation Oncology, Biology, Physics·G P AmorinoH Choy
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·M N SalehD J Buchsbaum
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·P M Harari, S M Huang
Apr 21, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T ServideiR Riccardi
Feb 6, 2004·Head & Neck·Andrew Simpson JonesDavid John Husband
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Kenneth A FoonGisela M Schwab
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tania CrombetAgustín Lage
Jul 30, 2005·Expert Opinion on Biological Therapy·Barbara Burtness
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David G PfisterMichael J Zelefsky
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shailaja Kalyankrishna, Jennifer R Grandis
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Ami Citri, Yosef Yarden
Jan 20, 2007·International Journal of Cancer. Journal International Du Cancer·Niklas ReimersJens P Klussmann
Jan 30, 2007·Nature Clinical Practice. Oncology·Tanguy Y SeiwertEverett E Vokes
May 1, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Imjai ChitapanaruxJudith Ford
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Juliette ThariatK Kian Ang
Dec 19, 2007·Archives of Otolaryngology--head & Neck Surgery·Andrés López-Albaitero, Robert L Ferris
Mar 14, 2008·The New England Journal of Medicine·Fortunato Ciardiello, Giampaolo Tortora
May 14, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bhavna KumarThomas E Carey
Aug 15, 2008·Biotechnology Journal·Sigrid R RuulsPaul W H I Parren
Sep 12, 2008·The New England Journal of Medicine·Robert I Haddad, Dong M Shin
Jan 22, 2009·Cancer·Kathryn A GoldEdward S Kim
May 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Christina S KongQuynh-Thu Le
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Aug 12, 2009·Expert Opinion on Pharmacotherapy·Quintin PanTheodoros N Teknos
Sep 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Michael I KoukourakisConstantinos Kouskoukis
Apr 20, 2010·Cancer Causes & Control : CCC·Elaine M SmithLubomir P Turek
May 8, 2010·Cancer Biology & Therapy·Marta Osorio RodríguezTania Crombet
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Jun 12, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Angela HongBarbara Rose
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V GrégoireUNKNOWN EHNS-ESMO-ESTRO Guidelines Working Group
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danny RischinGrant A McArthur
Oct 27, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Ricard Mesía NinUNKNOWN SEOM (Spanish Society for Medical Oncology)

❮ Previous
Next ❯

Citations

Sep 7, 2016·Frontiers in Cell and Developmental Biology·Sean P KennedyDavid R Croucher
Feb 6, 2017·European Journal of Oral Sciences·Clarissa PrechtAlexander Gröbe
Aug 29, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rui ChenThomas M McIntyre
Nov 9, 2018·International Journal of Molecular Sciences·Toshimitsu YamaokaTohru Ohmori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Journal of the National Comprehensive Cancer Network : JNCCN
Bruce BrocksteinMark Agulnik
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Zain A HusainRoy H Decker
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Daniel Morgensztern, Ramaswamy Govindan
© 2022 Meta ULC. All rights reserved